SCHEMBL23920040

SCHEMBL23920040

O=C(O)c1ccccc1C1(C(=O)O)CCCCC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C1 Q04828 1/20 0.58
ALDH1A1 P00352 4/20 0.46
ALOX15 P16050 1/20 0.46
HDAC4 P56524 6/20 0.46
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.41
KDM4E B2RXH2 2/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
HMGB1 P09429 1/20 0.41
HPGD P15428 1/20 0.41
CA4 P22748 1/20 0.41
CA6 P23280 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
NAPRT Q6XQN6 1/20 0.41
CA14 Q9ULX7 1/20 0.41
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23920039 0.98 AKR1C1 (0.60) AKR1C1ALDH1A1ALOX15HDAC4MEN1
SCHEMBL22745669 0.94 AKR1C1 (0.55) AKR1C1ALDH1A1ALOX15HDAC4MEN1
SCHEMBL31189199 0.94 AKR1C1 (0.55) AKR1C1ALDH1A1ALOX15HDAC4MEN1
SCHEMBL27152666 0.89 AKR1C1 (0.58) AKR1C1HDAC4MEN1KMT2ASMN1; SMN2
SCHEMBL4871001 0.86 AKR1C1 (0.55) AKR1C1ALDH1A1HDAC4MEN1KMT2A
SCHEMBL6138693 0.86 AKR1C1 (0.46) AKR1C1ALDH1A1ALOX15HDAC4MEN1
SCHEMBL28008915 0.84 AKR1C1 (0.53) AKR1C1ALDH1A1HDAC4MEN1KMT2A
SCHEMBL2565642 0.83 ALDH1A1 (0.48) AKR1C1ALDH1A1ALOX15HDAC4MEN1
SCHEMBL3918459 0.81 AKR1C1 (0.62) AKR1C1ALDH1A1HDAC4MEN1KMT2A
SCHEMBL9260336 0.80 AKR1C1 (0.51) AKR1C1ALDH1A1ALOX15HDAC4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11572442-B2 Compound, polyimide resin and method of producing the same, photosensitive resin composition, patterning method and method of forming cured film, interlayer insulating film, surface protective film, and electronic component INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2023-02-07 US disclosed
US-20210317270-A1 NOVEL COMPOUND, POLYIMIDE RESIN AND METHOD OF PRODUCING THE SAME, PHOTOSENSITIVE RESIN COMPOSITION, PATTERNING METHOD AND METHOD OF FORMING CURED FILM, INTERLAYER INSULATING FILM, SURFACE PROTECTIVE FILM, AND ELECTRONIC COMPONENT SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11572442-B2 Compound, polyimide resin and method of producing the same, photosensitive resin composition, patterning method and method of forming cured film, interlayer insulating film, surface protective film, and electronic component BRIX1, RBX1, HAX1 AKR1C1 3015/4885ALDH1A1 3045/4885ALOX15 1375/4885
US-20210317270-A1 NOVEL COMPOUND, POLYIMIDE RESIN AND METHOD OF PRODUCING THE SAME, PHOTOSENSITIVE RESIN COMPOSITION, PATTERNING METHOD AND METHOD OF FORMING CURED FILM, INTERLAYER INSULATING FILM, SURFACE PROTECTIVE FILM, AND ELECTRONIC COMPONENT BRIX1, HAX1, RBX1 AKR1C1 2768/4885ALDH1A1 2917/4885ALOX15 1544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.